Listed

Sotera Health Co

SHCNasdaqCIK 1822479HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$321.4mRevenue, Q2 FY2026, three months to 2026-06-30$321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 6, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$321.4mRevenue, Q2 FY2026, three months to 2026-06-30$321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure+9.2% on a year earlier
  • Gross margin55.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $178.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure−1.2 pts on a year earlier
  • Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
  • Net margin16.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $53.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure+14.0 pts on a year earlier
  • Diluted EPS$0.19Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure+533.3% on a year earlier
  • Free cash flow$42.0mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $88.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001822479-26-000047. Derived: 6-month figure less the 3-month figure.Capital expenditure: $46.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001822479-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure+60.6% on a year earlier

Last eight quarters

Full statements
Revenue$321.4mGross margin 55.4%
Diluted EPS$0.19, Q2 FY2026
Free cash flow$42.0m, Q2 FY2026
Sotera Health Co, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m285Revenue, Q3 FY2024, three months to 2024-09-30$285.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure290Revenue, Q4 FY2024, three months to 2024-12-31$290.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure255Revenue, Q1 FY2025, three months to 2025-03-31$254.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure294Revenue, Q2 FY2025, three months to 2025-06-30$294.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure311Revenue, Q3 FY2025, three months to 2025-09-30$311.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure303Revenue, Q4 FY2025, three months to 2025-12-31$303.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure280Revenue, Q1 FY2026, three months to 2026-03-31$280.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure321Revenue, Q2 FY2026, three months to 2026-06-30$321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure
Gross margin%55.4%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $158.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Revenue: $285.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure56.6%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $164.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Revenue: $290.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure53.2%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $135.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Revenue: $254.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure56.6%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $166.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Revenue: $294.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure57.0%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $177.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Revenue: $311.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure54.7%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $165.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Revenue: $303.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure52.5%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $147.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Revenue: $280.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure55.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $178.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure
Operating margin%28.2%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $80.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001822479-24-000049.Revenue: $285.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure30.0%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $87.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001822479-25-000015. Derived: 12-month figure less the 9-month figure.Revenue: $290.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%6.0%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Revenue: $285.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure4.2%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Revenue: $290.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(5.2%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Revenue: $254.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure2.7%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $8.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Revenue: $294.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure15.5%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $48.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Revenue: $311.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figure11.5%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $34.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Revenue: $303.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure9.5%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $26.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Revenue: $280.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure16.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $53.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure
Diluted EPS$ per share0.06Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figurenot reported (Diluted EPS not reported)(0.05)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure0.03Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure0.17Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001822479-25-000054.Report this figurenot reported (Diluted EPS not reported)0.09Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure0.19Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001822479-26-000047.Report this figure
Free cash flow$m61.1Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $97.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001822479-25-000054. Derived: 9-month figure less the 6-month figure.Capital expenditure: $36.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001822479-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure(10.2)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $55.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Capital expenditure: $65.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure35.6Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $55.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Capital expenditure: $19.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure26.2Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $57.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001822479-26-000047. Derived: 6-month figure less the 3-month figure.Capital expenditure: $31.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001822479-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure35.0Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $71.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001822479-25-000054. Derived: 9-month figure less the 6-month figure.Capital expenditure: $36.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001822479-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure52.4Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $103.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Capital expenditure: $50.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001822479-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(16.7)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $29.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Capital expenditure: $46.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001822479-26-000031.Report this figure42.0Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $88.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001822479-26-000047. Derived: 6-month figure less the 3-month figure.Capital expenditure: $46.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001822479-26-000047. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.16bnGross margin 55.5%
Diluted EPS$0.27, FY2025
Free cash flow$149.2m, FY2025
Sotera Health Co, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m931Revenue, FY2021, twelve months to 2021-12-31$931.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001822479-24-000011.Report this figure1,004Revenue, FY2022, twelve months to 2022-12-31$1.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001822479-25-000015.Report this figure1,049Revenue, FY2023, twelve months to 2023-12-31$1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure1,100Revenue, FY2024, twelve months to 2024-12-31$1.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure1,164Revenue, FY2025, twelve months to 2025-12-31$1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure
Gross margin%55.7%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $518.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-27, accession 0001822479-24-000011.Revenue: $931.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001822479-24-000011.Report this figure55.5%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $557.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-27, accession 0001822479-25-000015.Revenue: $1.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001822479-25-000015.Report this figure55.0%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $577.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001822479-26-000015.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure54.7%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $602.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001822479-26-000015.Revenue: $1.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure55.5%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $645.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001822479-26-000015.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure
Operating margin%27.6%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $256.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0001822479-24-000011.Revenue: $931.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001822479-24-000011.Report this figure24.7%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $248.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001822479-25-000015.Revenue: $1.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001822479-25-000015.Report this figure26.4%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $276.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001822479-25-000015.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure27.0%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $297.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001822479-25-000015.Revenue: $1.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figurenot reported (Operating income not reported)
Net margin%12.5%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $116.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0001822479-24-000011.Revenue: $931.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001822479-24-000011.Report this figure(23.3%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$233.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001822479-25-000015.Revenue: $1.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-27, accession 0001822479-25-000015.Report this figure4.9%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $51.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001822479-26-000015.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure4.0%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $44.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001822479-26-000015.Revenue: $1.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure6.7%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $77.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001822479-26-000015.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure
Diluted EPS$ per share0.41Diluted EPS, FY2021, twelve months to 2021-12-31$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-27, accession 0001822479-24-000011.Report this figure(0.83)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0001822479-25-000015.Report this figure0.18Diluted EPS, FY2023, twelve months to 2023-12-31$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure0.16Diluted EPS, FY2024, twelve months to 2024-12-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure0.27Diluted EPS, FY2025, twelve months to 2025-12-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure
Free cash flow$m179Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $281.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-27, accession 0001822479-24-000011.Capital expenditure: $102.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-27, accession 0001822479-24-000011.Report this figure95.6Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $278.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0001822479-25-000015.Capital expenditure: $182.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0001822479-25-000015.Report this figure(363)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$147.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001822479-26-000015.Capital expenditure: $215.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure45.1Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $224.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001822479-26-000015.Capital expenditure: $179.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure149Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $287.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001822479-26-000015.Capital expenditure: $138.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001822479-26-000015.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Sotera Health Co
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Sessa Capital IM, L.P.2026-06-30$480.1m27,050,000Added+4,000,000
Darsana Capital Partners LP2026-06-30$479.3m27,000,000Added+1,000,000
BlackRock, Inc.2026-06-30$428.6m24,148,424Added+3,298,845
Sculptor Capital LP2026-06-30$426.0m24,000,000Added+2,282,272
Sachem Head Capital Management LP2026-06-30$276.2m15,560,000Added+3,915,000
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$216.0m12,170,699Added+1,435,693
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$212.0m11,946,341Added+1,337,624
AQR CAPITAL MANAGEMENT LLC2026-06-30$186.4m10,734,313Added+4,013,550
Jupiter Topco LLC2026-06-30$149.1m8,402,106Not compared
STATE STREET CORP2026-06-30$147.8m8,324,321Added+1,302,695

Recent filings

All 379 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Sotera Health Co, recent filings
FiledFormWhat it isAccession number
2026-08-1411:17 ET8-K5.02 Departure or appointment of officers or directors0001822479-26-000050
2026-08-0620:04 ET10-QQuarterly reportPeriod 2026-06-300001822479-26-000047
2026-08-0611:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001822479-26-000044
2026-05-2220:09 ET8-K5.07 Shareholder vote results0001822479-26-000034
2026-05-2020:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-232585
2026-05-1320:11 ET8-K1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-221630
2026-05-0520:19 ET10-QQuarterly reportPeriod 2026-03-310001822479-26-000031
2026-05-0511:13 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001822479-26-000028
2026-04-0820:30 ETDEF 14AProxy statementPeriod 2026-05-210001104659-26-040937
2026-03-1611:14 ET8-K5.02 Departure or appointment of officers or directors0001822479-26-000019

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 24, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1822479
Tickers
SHC
Exchange
Nasdaq
SIC code
8090 Services-Misc Health & Allied Services, NEC
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
Sotera Health Topco, Inc. (to 2020-10-09)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.